Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

19 results about "Analyte" patented technology

An analyte, component (in clinical chemistry), or chemical species is a substance or chemical constituent that is of interest in an analytical procedure.

Methods and systems for utilizing quantitative imaging

ActiveUS20190159737A1Easy to implementImage enhancementMedical imagingBiological propertyAnalyte
Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties / analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties / analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
Owner:ELUCID BIOIMAGING INC

Sample element for use in material analysis

InactiveUS20050106749A1Analysis using chemical indicatorsMaterial analysis by observing effect on chemical indicatorAbsorption ratioAnalyte
A system and method are provided for determining a concentration of an analyte in a material sample. The method includes providing a sample element with a sample chamber at least partially defined by at least one window formed from a material having greater than about 1% wavelength-domain variation in absorbtivity of electromagnetic radiation incident thereon. The method further includes employing the sample element with an analyte detection system which determines the concentration of the analyte with clinically acceptable accuracy.
Owner:OPTISCAN BIOMEDICAL

Devices, methods and systems for low volume microarray processing

InactiveUS6913931B2Reduction and elimination of liquid retention interfaceAvoid the needMaterial nanotechnologyAnalysis using chemical indicatorsAnalyteFluorescence
Devices, methods and systems for low volume microarray processing are disclosed. The microarray devices preferably include a plurality of reactant sites on a reactant surface. The reactant sites include reactants that operate to capture one or more selected analytes that can then be detected based on an electromagnetic signal, e.g., fluorescence, that is emitted by each analyte in response to excitation energy incident on the microarray device. Mixing and/or distribution of the analyte sample over the reactant surface is accomplished by tilting the reactant surface such that the analyte sample flows over the reactant surface under the force of gravity. The tilting is performed such that a portion of the analyte sample accumulates in a bead along a first edge of the reactant surface. The reactant surface is then tilted in a different direction such that a portion of the analyte sample flows over the reactant surface and accumulates at a second edge. The reactant surface preferably generates sufficient capillary forces with the analyte sample such that the analyte sample is retained on the reactant surface. The tilting and resultant flow may be performed as many times as necessary to obtain the desired mixing and/or distribution of analyte sample over the reactant surface.
Owner:3M INNOVATIVE PROPERTIES CO

Quantitative imaging for detecting histopathologically defined plaque fissure non-invasively

PendingUS20220012877A1Easy to implementImage enhancementImage analysisBiological propertyAnalyte
Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties / analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties / analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
Owner:ELUCID BIOIMAGING INC

Using asymmetrical flow focusing to detect and enumerate magnetic particles in microscale flow systems with embedded magnetic-field sensors

InactiveUS20090001024A1Water/sewage treatment by magnetic/electric fieldsFiltration separationMagnetic markerAnalyte
Improved detection and enumeration of magnetic particles in a flowing stream by enveloping the particle-containing sample stream with buffer streams from the sides and from the top, thus individualizing the particles and navigating the sample stream as a single-file flow into the proximity of sensors embedded underneath the flow channel. At the same time, larger physical size of the flow channel alleviates problems such as channel clogging. Magnetic particles can represent any analyte of interest, such as biomolecules or bacterial cells, which are labeled with magnetic labels.
Owner:IOWA STATE UNIV RES FOUND INC

Analyte concentration measuring method, particle containing agglutinated fluorescent material, and inspection device

InactiveUS20190226988A1Satisfactory detection sensitivityMaterial analysis by observing effect on chemical indicatorFluorescence/phosphorescenceAggregation-induced emissionAnalyte
This analyte concentration measuring method including:preparing a mixed solution by mixing a sample solution containing an analyte, with a solution containing aggregation-induced emission fluorescent material-containing particles that have a binding partner which binds with the analyte and that agglutinate and fluoresce when the analyte binds to the binding partner;measuring the fluorescence intensity generated from the aggregation-induced emission fluorescent material-containing particles in the mixed solution; andcomparing a fluorescence intensity calibration curve for analyte concentration with the fluorescence intensity, and associating the fluorescence intensity with the analyte concentration in the mixed solution. Employing agglutinating-luminescent-material-containing particles enables measurements to be carried out with a satisfactory detection sensitivity while suppressing background fluorescence.
Owner:SEKISUI CHEM CO LTD +1

Reduction of interferences in immunoassays

PendingUS20200400654A1Easy to detectReliable resultsBiological testingAssay labelsAnalyteChemical compound
The present invention relates to a method for determining an analyte in a sample, comprising a) contacting said sample with at least a first and a second detector compound; b) determining the amount of complexes comprising at least one detector compound; and, c) determining said analyte in a sample based on the result of step b), wherein said first detector compound comprises a first binding moiety and a first label, and said second detector compound comprises a second binding moiety and a second label, and wherein the first label and the second label are non-identical. The present invention further relates to a kit for detecting an analyte in a sample, comprising at least a first and a second detector compound for said analyte, wherein said first detector compound comprises a first binding moiety and a first label, and said second detector compound comprises a second binding moiety and a second label, and wherein the first label and the second label are non-identical; and to a device for determining an analyte in a sample, comprising at least a first and a second detector compound for said analyte, wherein said first detector compound comprises a first binding moiety and a first label, and said second detector compound comprises a second binding moiety and a second label, and wherein the first label and the second label are non-identical; and means for determining at least one signal obtained from said first label and said second label; and to the use of a composition comprising at least a first and a second detector compound for detecting an analyte, wherein said first detector compound comprises a first binding moiety and a first label, and said second detector compound comprises a second binding moiety and a second label, and wherein the first label and the second label are non-identical.
Owner:ROCHE DIAGNOSTICS OPERATIONS INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products